Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Hebert

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
American Journal of Epidemiology|September 15, 1993
Modification of increasing systolic blood pressure in the elderly during the 1980sR J Glynn, T S Field, S Satterfield, et al.
Neurology|July 28, 2004
Modulation of the renin-angiotensin-aldosterone system for the secondary prevention of strokeS I Sokol, E L Portnay, J P Curtis, et al.
Annals of Epidemiology|March 1, 1995
Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Trials of Hypertension Prevention (TOHP) Collaborative Research GroupL J Appel, P R Hebert, J D Cohen, et al.
JAMA|February 28, 1996
Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort studyC H Hennekens, I M Lee, N R Cook, et al.
American Journal of Epidemiology|October 1, 1989
A prospective study of high blood pressure and cardiovascular disease in womenN H Fiebach, P R Hebert, M J Stampfer, et al.
Annals of Epidemiology|October 1, 1990
A comparison of two automated monitors in the measurement of blood pressure reactivity. Trials of Hypertension Prevention Collaborative Research GroupB A Rosner, L J Appel, J M Raczynski, et al.
Circulation|October 1, 1993
Height and incidence of cardiovascular disease in male physiciansP R Hebert, J W Rich-Edwards, J E Manson, et al.
Annals of Epidemiology|May 1, 1992
Baseline characteristics of participants in phase I of the Trials of Hypertension PreventionP K Whelton, P R Hebert, J Cutler, et al.
Journal of Thrombosis and Haemostasis : JTH|November 10, 2006
Gender-specific correlations of plasminogen activator inhibitor-1 and tissue plasminogen activator levels with cardiovascular disease-related traitsF W Asselbergs, S M Williams, P R Hebert, et al.
Hypertension (Dallas, Tex. : 1979)|October 1, 1993
Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research GroupS K Kumanyika, P R Hebert, J A Cutler, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
American Journal of Epidemiology|September 15, 1993
Modification of increasing systolic blood pressure in the elderly during the 1980sR J Glynn, T S Field, S Satterfield, et al.
Neurology|July 28, 2004
Modulation of the renin-angiotensin-aldosterone system for the secondary prevention of strokeS I Sokol, E L Portnay, J P Curtis, et al.
Annals of Epidemiology|March 1, 1995
Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Trials of Hypertension Prevention (TOHP) Collaborative Research GroupL J Appel, P R Hebert, J D Cohen, et al.
JAMA|February 28, 1996
Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort studyC H Hennekens, I M Lee, N R Cook, et al.
American Journal of Epidemiology|October 1, 1989
A prospective study of high blood pressure and cardiovascular disease in womenN H Fiebach, P R Hebert, M J Stampfer, et al.
Annals of Epidemiology|October 1, 1990
A comparison of two automated monitors in the measurement of blood pressure reactivity. Trials of Hypertension Prevention Collaborative Research GroupB A Rosner, L J Appel, J M Raczynski, et al.
Circulation|October 1, 1993
Height and incidence of cardiovascular disease in male physiciansP R Hebert, J W Rich-Edwards, J E Manson, et al.
Annals of Epidemiology|May 1, 1992
Baseline characteristics of participants in phase I of the Trials of Hypertension PreventionP K Whelton, P R Hebert, J Cutler, et al.
Journal of Thrombosis and Haemostasis : JTH|November 10, 2006
Gender-specific correlations of plasminogen activator inhibitor-1 and tissue plasminogen activator levels with cardiovascular disease-related traitsF W Asselbergs, S M Williams, P R Hebert, et al.
Hypertension (Dallas, Tex. : 1979)|October 1, 1993
Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research GroupS K Kumanyika, P R Hebert, J A Cutler, et al.
Pageof 4